<DOC>
	<DOCNO>NCT02792946</DOCNO>
	<brief_summary>Compare efficacy safety surfolase CR tablet surfolate capsule patient acute bronchitis</brief_summary>
	<brief_title>Compare Efficacy Safety Surfolase CR Tablet With Surfolase Capsule Patients With Acute Bronchitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<criteria>1 . Male female age 19 65 year , inclusive 2 . Patients acute bronchitis accompany cough include sputum within 48 hour 5 Bronchitis severity score ( BSS ) Screening 3 . Patients agree participate clinical trial sign inform consent form 1 . Patients suspicious diagnose pneumonia 2 . Patients chronic bronchitis , Chronic Obstructive Pulmonary Disease ( COPD ) , bronchiolitis , asthma , bronchial asthma 3 . Patients active infection need administration antibiotic 4 . Patients myocardial infarction , congestive heart failure 5 . Patients renal disorder liver disorder 6 . Patients hypotension hypertension 7 . Patients history epilepsy 8 . Patients hyperthyroidism 9 . Patients gastroduodenal ulcer 10 . Patients sever hypoxemia 11 . Patients drug therapy plan ; antibiotic , antivirus , angiotensin convert enzyme ( ACE ) inhibitor systemic inhalation glucocorticosteroids : 2 week prior administration investigational product termination clinical trial Angiotension II receptor blocker ( ARB ) , secretolytics/mucolytics , expectorant , antitussive , herb medicine antitussive expectorant effect : 2 day prior administration investigational product termination clinical trial Analgesics except acetaminophen , antihistamine , Î²2agonists , bronchodilator include anticholinergic agent , xanthine derivative , central nervous system stimulant , drug know interaction acebrophylline ( cimetidine , alloprinol , oral anticoagulant , furosemide , reserpine , barbiturate , phenytoin ) symtomatic therapy therapy acute bronchitis : whole period clinical trial 12 . Smokers 13 . Patients history drug hypersensitivity allergic reaction component investigational product similar drug 14 . Patients pregnant and/or breast feeding . 15 . Patients intention use appropriate contraceptive plan become pregnant 16 . Patients administrationb investigational product medical device clinical trial 4 week prior participation clinical trial 17 . Patients identified inappropriate investigator participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>